193 related articles for article (PubMed ID: 37925175)
1. Plumbagin has an inhibitory effect on the growth of TSCC PDX model and it enhances the anticancer efficacy of cisplatin.
Xin Y; Jiang Q; Liu C; Qiu J
Aging (Albany NY); 2023 Nov; 15(21):12225-12250. PubMed ID: 37925175
[TBL] [Abstract][Full Text] [Related]
2. Plumbagin Enhances the Anticancer Efficacy of Cisplatin by Increasing Intracellular ROS in Human Tongue Squamous Cell Carcinoma.
Xue D; Pan ST; Zhou X; Ye F; Zhou Q; Shi F; He F; Yu H; Qiu J
Oxid Med Cell Longev; 2020; 2020():5649174. PubMed ID: 32308804
[TBL] [Abstract][Full Text] [Related]
3. CXCR4 enhances cisplatin resistance of human tongue squamous cell carcinoma.
Zhuang XM; Zhou B
J Oral Pathol Med; 2019 Feb; 48(2):122-128. PubMed ID: 30554431
[TBL] [Abstract][Full Text] [Related]
4. Plumbagin-mediating GLUT1 suppresses the growth of human tongue squamous cell carcinoma.
Na S; Zhang J; Zhou X; Tang A; Huang D; Xu Q; Xue D; Qiu J
Oral Dis; 2018 Sep; 24(6):920-929. PubMed ID: 29080392
[TBL] [Abstract][Full Text] [Related]
5. Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential.
Zhao L; Ren Y; Tang H; Wang W; He Q; Sun J; Zhou X; Wang A
Oncotarget; 2015 Dec; 6(42):44538-50. PubMed ID: 26517090
[TBL] [Abstract][Full Text] [Related]
6. miR-23a promotes cisplatin chemoresistance and protects against cisplatin-induced apoptosis in tongue squamous cell carcinoma cells through Twist.
Peng F; Zhang H; Du Y; Tan P
Oncol Rep; 2015 Feb; 33(2):942-50. PubMed ID: 25501015
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity mechanisms of plumbagin in drug-resistant tongue squamous cell carcinoma.
Xue D; Zhou X; Qiu J
J Pharm Pharmacol; 2021 Mar; 73(1):98-109. PubMed ID: 33791802
[TBL] [Abstract][Full Text] [Related]
8. TRG-AS1 is a potent driver of oncogenicity of tongue squamous cell carcinoma through microRNA-543/Yes-associated protein 1 axis regulation.
He S; Wang X; Zhang J; Zhou F; Li L; Han X
Cell Cycle; 2020 Aug; 19(15):1969-1982. PubMed ID: 32615889
[TBL] [Abstract][Full Text] [Related]
9. SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/β-catenin pathway.
Xie SL; Fan S; Zhang SY; Chen WX; Li QX; Pan GK; Zhang HQ; Wang WW; Weng B; Zhang Z; Li JS; Lin ZY
Int J Cancer; 2018 Mar; 142(6):1252-1265. PubMed ID: 29071717
[TBL] [Abstract][Full Text] [Related]
10. Establishment of a Jaw Fibrosarcoma Patient-Derived Xenograft and Evaluation of the Tumor Suppression Efficacy of Plumbagin Against Jaw Fibrosarcoma.
Xin Y; Li S; Jiang Q; Hu F; He Y; Zhang J
Front Oncol; 2020; 10():1479. PubMed ID: 32974176
[No Abstract] [Full Text] [Related]
11. RIPK4 is downregulated in poorly differentiated tongue cancer and is associated with migration/invasion and cisplatin-induced apoptosis.
Wang X; Zhu W; Zhou Y; Xu W; Wang H
Int J Biol Markers; 2014 Jun; 29(2):e150-9. PubMed ID: 24519546
[TBL] [Abstract][Full Text] [Related]
12. High SOX8 expression promotes tumor growth and predicts poor prognosis through GOLPH3 signaling in tongue squamous cell carcinoma.
Chen S; Li H; Li X; Chen W; Zhang X; Yang Z; Chen Z; Chen J; Zhang Y; Shi D; Song M
Cancer Med; 2020 Jun; 9(12):4274-4289. PubMed ID: 32307911
[TBL] [Abstract][Full Text] [Related]
13. Plumbagin Enhances the Anticancer Effects of PF Chemotherapy via Downregulation of the PI3K/AKT/mTOR/p70S6K Pathway in Human Tongue Squamous Cell Carcinoma.
Pan ST; Ye FF; Huang G; Qiu JX
J Oncol; 2023; 2023():8306514. PubMed ID: 36814557
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-27a promotes tumorigenesis in tongue squamous cell carcinoma by enhancing proliferation, migration and suppressing apoptosis.
Chen H; Dong Z; Chen Y; Cui Y; Song P; Yang K
Eur Arch Otorhinolaryngol; 2021 Nov; 278(11):4557-4567. PubMed ID: 33912994
[TBL] [Abstract][Full Text] [Related]
15. FSCN1 is an effective marker of poor prognosis and a potential therapeutic target in human tongue squamous cell carcinoma.
Chen Y; Tian T; Li ZY; Wang CY; Deng R; Deng WY; Yang AK; Chen YF; Li H
Cell Death Dis; 2019 May; 10(5):356. PubMed ID: 31043585
[TBL] [Abstract][Full Text] [Related]
16. Overexpression long non-coding RNA LINC00673 is associated with poor prognosis and promotes invasion and metastasis in tongue squamous cell carcinoma.
Yu J; Liu Y; Gong Z; Zhang S; Guo C; Li X; Tang Y; Yang L; He Y; Wei F; Wang Y; Liao Q; Zhang W; Li X; Li Y; Li G; Xiong W; Zeng Z
Oncotarget; 2017 Mar; 8(10):16621-16632. PubMed ID: 28039470
[TBL] [Abstract][Full Text] [Related]
17. [Effect of plumbagin on epithelial-mesenchymal transition and underlying mechanisms in human tongue squamous cell carcinoma cells].
Li B; Pan ST; Qiu JX
Zhonghua Kou Qiang Yi Xue Za Zhi; 2017 Jul; 52(7):421-426. PubMed ID: 29972906
[No Abstract] [Full Text] [Related]
18. Yes-associated protein 1 exerts its tumor-promoting effects and increases cisplatin resistance in tongue squamous cell carcinoma cells by dysregulating Hippo signal pathway.
Guan H; Deng L
Anticancer Drugs; 2022 Apr; 33(4):352-361. PubMed ID: 35266885
[TBL] [Abstract][Full Text] [Related]
19. Cancer-associated fibroblasts confer cisplatin resistance of tongue cancer via autophagy activation.
Liao JK; Zhou B; Zhuang XM; Zhuang PL; Zhang DM; Chen WL
Biomed Pharmacother; 2018 Jan; 97():1341-1348. PubMed ID: 29156523
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of long noncoding RNA urothelial cancer-associated 1 enhances cisplatin chemosensitivity in tongue squamous cell carcinoma cells.
Wang J; Li L; Wu K; Ge W; Zhang Z; Gong L; Yuan D
Pharmazie; 2016 Oct; 71(10):598-602. PubMed ID: 29441929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
